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The alarming spread of bacterial resistance to traditional antibiotics has warranted the
study of alternative antimicrobial agents. Quorum sensing (QS) is a chemical cell-to-cell
communication mechanism utilized by bacteria to coordinate group behaviors and
establish infections. QS is integral to bacterial survival, and therefore provides a unique
target for antimicrobial therapy. In this study, silicon dioxide nanoparticles (Si-NP) were
engineered to target the signaling molecules [i.e., acylhomoserine lactones (HSLs)]
used for QS in order to halt bacterial communication. Specifically, when Si-NP were
surface functionalized with β-cyclodextrin (β-CD), then added to cultures of bacteria
(Vibrio fischeri), whose luminous output depends upon HSL-mediated QS, the cell-to-cell
communication was dramatically reduced. Reductions in luminescence were further
verified by quantitative polymerase chain reaction (qPCR) analyses of luminescence
genes. Binding of HSLs to Si-NPs was examined using nuclear magnetic resonance
(NMR) spectroscopy. The results indicated that by delivering high concentrations of
engineered NPs with associated quenching compounds, the chemical signals were
removed from the immediate bacterial environment. In actively-metabolizing cultures,
this treatment blocked the ability of bacteria to communicate and regulate QS, effectively
silencing and isolating the cells. Si-NPs provide a scaffold and critical stepping-stone for
more pointed developments in antimicrobial therapy, especially with regard to QS—a
target that will reduce resistance pressures imposed by traditional antibiotics.
Keywords: nanomedicine, nanoparticles, quorum sensing, quorum quenching
Introduction
Excessive use of antibiotics has resulted in widespread bacterial resistance and poses a signif-
icant public health threat. Non-cytotoxic methods for controlling infections, such as interfer-
ence in bacterial communication, are necessary to fight pathogenic infections while limiting
the risk of antibiotic resistance (Rasko and Sperandio, 2010; Schuster et al., 2013). Quorum
sensing (QS) is a chemical communication scheme used by bacteria to coordinate their activi-
ties within a biofilm, and it regulates many translational features that make bacteria dangerous
(Davies, 1998; Ng and Bassler, 2009; Hoiby et al., 2010). One of the most significant challenges
in the treatment of chronic infections is the effective delivery of drugs to bacterial biofilms.
The importance of nanoparticle-based therapies is imperative to the treatment of biofilm infec-
tions. Biofilms are surface-associated bacterial communities living in a highly-organized structure
at a liquid interface (Costerton et al., 1987), and have been estimated to be responsible for
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80% of hospital-acquired infections (Davies, 2003). The protec-
tive nature of bacterial biofilms makes them able to physically
limit antibiotic penetration (Stewart et al., 2001; Canton and
Morosini, 2011), quickly regulate multidrug eﬄux pumps and
stress response genes (Davies, 2003; Hoiby et al., 2010), induce a
biofilm-specific phenotype (Allison et al., 2011), and easily trade
and enhance antibiotic resistance genes among their bacterial
members (Madsen et al., 2012).
FIGURE 1 | Schematic of β-cyclodextrin coated silicon dioxide
nanoparticle.
FIGURE 2 | Schematic of nanoparticle-based silencing of bacterial
quorum sensing (QS). (A) Diagram of the Gram-negative bacterium Vibrio
fischeri lux operon used in luminescence during QS using acyl-homoserine
lactones (HSL). Triangles represent 3OC6-HSL. LuxR/3OC6-HSL complex
initiates bilateral transcription of lux operon. LuxI produces 3OC6-HSL. Inset:
A one-liter V. fischeri culture flask luminescing after treatment with HSLs. (B)
Diagram of V. fischeri during nanoparticle treatment. Binding of HSLs by
Si-NPs quenches QS and subsequent gene expression in lux. (C) Changes
in maximum bioluminescence by V. fischeri during exposure to 2µM
3OC6-HSL, with either β-CD or β-CD functionalized Si-NPs. Error bars
represent standard error of the mean (n = 3). Asterisks indicate significance
(P = 0.05) by ANOVA.
Silicon dioxide nanoparticles (Si-NPs) have a broad range
of applications within the biomedical and industrial fields due
to their high biocompatibility and controllable particle size (De
et al., 2008; Malvindi et al., 2012; Wang and Benicewicz, 2013).
Inspired by developments in the field of drug delivery, we
have designed Si-NPs (Figure 1) to carry compounds that will
quench signal molecules. Removal of signals from the immedi-
ate bacterial environment prevents the molecule from reaching
its cognate receptor, thus inhibiting the signal/receptor interac-
tion, and interfering with down-stream regulation. We hypoth-
esized that this process will quench signal molecules, “turn off”
QS, and silence bacterial communication (schematic seen in
Figures 2A,B).
β-cyclodextrin (β-CD) has been shown to non-specifically
bind N-acyl-L-homoserine lactone (HSL) molecules (Kato et al.,
2006), a common class of signal molecules produced by Gram-
negative bacteria. β-CD consists of seven glucopyranose units
bound by α-1,4-glycosidic linkages. Thismolecule takes the shape
of a truncated cone with a hydrophilic exterior and a slightly
hydrophobic interior. β-CD was chosen as a model compound
because the formation of a CD complex can be detected and
because the reactivity of a guest molecule in a CD complex is sub-
sequently modified (Szejtli, 1998). In many cases, the CD accel-
erates the various reactions associated with the guest molecule
and modifies the reaction pathway. Herein we present a new
approach to disrupting bacterial QS with Si-NPs that have been
surface-functionalized with β-CDs.
To test the quorum quenching function of the Si-NPs, the
marine bacterium Vibrio fischeri was employed as a model.
V. fischeri relies on N-acyl-L-homoserine lactone molecules
to trigger coordinated activities such as colonization and bio-
luminescence in a threshold dependent manner during QS
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(Kaplan and Greenberg, 1985). Specifically, V. fischeri synthe-
sizes and responds to N-3-oxo-hexanoyl-L-homoserine lactone
(3OC6-HSL) (Eberhard et al., 1981; Engebrecht and Silverman,
1984) and N-octanoyl-L-homoserine lactone (C8-HSL) (Enge-
brecht et al., 1983) via the lux operon, which is also responsible
for the proteins that synthesize luminescent luciferase (Stevens
et al., 1994). HSLs are also used by pathogenic bacteria such
as Actinobacillus, Salmonella, Pseudomonas, and other Vibrio
species to regulate their respective QS genes (Defoirdt, 2013;
LaSarre and Federle, 2013; Li et al., 2013b).
In this study, the fold change in the luxA and luxR transcrip-
tion of V. fischeri was quantified to determine the activity of
the lux operon during exposure to β-CD. LuxA forms the alpha
subunit of luciferase and was used to monitor bacterial lumines-
cence. LuxR is a receptor for both 3OC6-HSL and C8-HSL, and
initiates the lux operon, and was used to monitor signal pro-
duction. In the natural ocean habitat, this QS function allows
V. fischeri to establish a symbiotic relationship with the Hawaiian
bobtail squid (Euprymna scolopes) and provide counterillumina-
tion for the squid (Visick et al., 2000). Environmental conditions
are essential for the proper functioning of V. fischeri biolumi-
nescence. A symbiotic culture produces approximately 1000-fold
brighter bioluminescence and more 3OC6-HSL than cultured
cells at the same density (Boettcher and Ruby, 1990). Therefore,
HSLs must be added to the cultures to induce QS and visible
bioluminescence in vitro.
In this study we have engineered nanoparticles that weaken
the communication network of bacteria, rather than directly tar-
get the viability of cells. The functionalized Si-NPs bind small
signal molecules as they diffuse between cells, and subsequently
block bacterial QS. Using growth and transcription studies, we
demonstrate that this novel technology can be used to directly
influence bacterial communication and activities regulated by
QS, and offer a promising tool that can be further developed
to unravel the virulence of pathogenic bacteria. V. fischeri was
used in its planktonic form to establish the utility of the func-
tionalized NPs in a simple environment. Also, this bacterium was
used because its QS mechanism is well-established in the litera-
ture and can be readily detected (by luminescence) in the labora-
tory. A biofilm model has not yet been employed here because of
the inherent complexity found in a biofilm, and the subsequent
difficulty in monitoring the QS response.
Results
Si-NPs Carry β-cyclodextrin
The unique properties of surface-functionalized Si-NPs make
them ideal for targeting the multiple avenues of bacterial
defenses and weakening an infection. Surface functionalization
plays a critical role in tailoring the properties of Si-NPs via
well-developed surface chemistry (Li et al., 2013a, 2014). For this
study, the synthesized β-CD functionalized Si-NPs were puri-
fied via dialysis to remove un-reacted (i.e., free) β-CD molecules,
as confirmed by 1H NMR (Supplementary Figure 1). Thermo-
gravimetric analysis (TGA) confirmed that the monolayer of β-
CD accounted for 2.78% of the total weight of particles and
indicated a surface graft density of 0.27 and 0.11 groups/nm2
for the 15 and 50 nm nanoparticles, respectively (Supplementary
Figure 2).
β-Cyclodextrin Binds HSLs in Solution
NMR spectroscopy was used to determine binding strengths
between β-CD and HSLs. NMR diffusion experiments demon-
strated that both C8-HSL (produced by V. fischeri) and C6-HSL
(produced by Pseudomonas aeruginosa) could bind to β-CD in a
1:1 ratio; however, there was no evidence that 3OC6-HSL (also
produced by V. fischeri) formed a complex with β-CD. Further
calculations revealed the binding and dissociation constants of
the experimental complexes. The binding between the HSLs and
β-CD accounted for only 17% of C6-HSL and 35% of C8-HSL
at any one time in the 1:1 solution (Supplementary Tables 1, 2).
Despite this relatively low binding, we proceeded to quantify the
quenching ability of β-CD in vitro. Using growth and lumines-
cence studies we observed the influence of β-CD on V. fischeri
bioluminescence.
Nanoparticles Enhance Ability of β-Cyclodextrin
to Quench HSLs and Dim Bioluminescence
V. fischeri cultures grown in the presence of 2µM 3OC6-HSL
exhibited strong bioluminescence and normal growth. When
treated with concentrations of free β-CD ranging from 250 nM
to 7mM, the growth study showed that exposure to 2mM β-
CD resulted in the most significant decrease in bioluminescence
(Supplementary Figure 3). A preliminary analyses of β-CD func-
tionalized Si-NPs with 2µM 3OC6-HSL demonstrated that the
β-CD moietie was significantly more-effective at dimming biolu-
minescence of V. fischeri when functionalized to a Si-NP than it
was as a free-compound (Figure 2C). Statistical significance for
all experiments was determined by a repeated measures analy-
sis of variance test followed by an aposteriori pairwise muliple
comparision procedure (SigmaPlot, Systat Software, San Jose,
CA). Because 2µM 3OC6-HSL likely exceeds the expected HSL
production of symbiotic V. fischeri cultures [which is unknown,
but luminescence is induced in the nanomolar range (Lupp and
Ruby, 2005)], and does not induce the lux operon like C8-HSL,
we altered the HSL conditions to more-closely mimic the natural
environment.
Growth experiments were repeated with V. fischeri cultured
with 125 nM 3OC6-HSL and 0.25 nM C8-HSL. Optical den-
sity and bioluminescence were monitored throughout growth to
determine the impact of free and functionalized β-CD. All cul-
tures were grown in defined minimal medium (Studer et al.,
2008), and therefore were not in a rich nutrient environment.
Additional growth studies indicated that the bacteria did not
thrive on β-CD or the various Si-NPs. Also, when all carbon
sources in the defined minimal medium were replaced with β-
CD, no growth occurred. Cultures grown without the addition
of HSLs produced negligible levels of bioluminescence. There-
fore, β-CD, with or without NPs, did not influence the growth
or relative health of the cells.
V. fischeri cultures grown in the presence of 125 nM
3OC6-HSL and 0.25 nM C8-HSL produced measureable
bioluminescence; although, bioluminescence in general was
lower compared to the cultures treated with 2µM 3OC6-HSL
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FIGURE 3 | Mean relative maximum bioluminescence per OD (600nm)
of V. fischeri during exposure to 125nM 3OC6-HSL and 0.25nM
C8-HSL treated with 250nM β-CD, bare 15nm Si-NPs, 155nM β-CD
functionalized 15nm Si-NPs, bare 50nm Si-NPs, or 133nM β-CD
functionalized 50nm Si-NPs. Error bars represent standard error of the
mean (n = 3). Asterisks indicate significance (P = 0.05).
(as indicated by the different scales in Figures 2C, 3). Our study
found that at environmentally-relevant levels of HSLs, biolumi-
nescence was significantly reduced in vitro by β-CD (P = 0.05).
By functionalizing β-CD to 50 nm NPs, 133 nM β-CD was
able to produce the same result as a 2x higher concentration
of free 250 nM β-CD (Figure 3). We found that 15 nm Si-NPs
with or without β-CD decreased bioluminescence to the same
extent, and thus may not have a significant role in dimming
luminescence.
The long half-life (relative to a 12-h growth experiment) of
luciferase likely contributed to the uncertainty in discerning sub-
tle changes in QS over time. To further examine the role of func-
tionalized and free β-CD in V. fischeri QS, we then examined
changes in transcription of the lux operon during exposure to
β-CD and β-CD functionalized Si-NPs.
lux Operon Down-Regulated in Presence of β-CD
Functionalized Si-NPs
Bioluminescence in V. fischeri is generated by the lux operon
and is activated by 3OC6-HSL and C8-HSL. Transcription of the
lux operon results in the production of luciferase, the enzyme
responsible for bioluminescence. Table 1 summarizes the fold-
changes calculated for luxA and luxR from the Ct values gen-
erated by qPCR with the Livak method (11Ct) of both HSL-
treated cultures.
The quantity of transcripts produced by untreated cultures
(controls) and cultures treated with 250 nM β-CD were not
markedly different, indicating that low concentrations of free
β-CD are ineffective in down-regulating luxA and luxR at envi-
ronmental levels of HSLs (data not shown). The addition of
TABLE 1 | Calculated fold change of transcription by V. fischeri after
treatment exposures to 125nM 3OC6- and 0.25nM C8-HSLs.
luxR luxA
no treatment (control) −1.4 4.8
250 nM β-CD −1.7 1.7
2mM β-CD −97.8 −39.1
15 nm bare-NPs −250.4 −432.9
15 nm 155 nM β-CD-NPs −245.7 −629.77
50 nm bare-NPs −1723.4 −365.8
50 nm 133 nM β-CD-NPs −2125.5 −2171.1
Negative values indicate down-regulation.
much higher (i.e., 2mM) β-CD significantly reduced the expres-
sion of luxA and luxR transcripts, as indicated by the calcu-
lated fold changes (P = 0.05). In an attempt to more effi-
ciently deliver β-CD to the bacterial cell, low concentrations
of β-CD were applied via Si-NPs. As Table 1 indicates, both
the functionalized and non-functionalized 15 nm Si-NPs reduced
the expression of luxA and luxR transcripts to a similar extent.
The data agree with the growth study, indicating that the influ-
ence of 15 nm Si-NPs functionalized with or without 155 nM
β-CD is indistinguishable. Conversely, treatment with the larger
nanoparticles (i.e., functionalized and non-functionalized 50 nm
Si-NPs) resulted in significantly different fold changes (P =
0.05). The 133 nM β-CD, when bound to functionalized 50 nm
Si-NPs, resulted in the greatest down-regulation of luxA and
luxR transcripts out of all treatments, demonstrating the strong
utility of this size of functionalized Si-NPs. The discontinu-
ity of the bioluminescence measurements between the growth
and transcription studies was likely influenced by the rela-
tively long half-life of bioluminescence, which contributed to
an inability to discern differences using bioluminescence during
growth.
Discussion
The bioluminescence and transcription studies indicate that the
15 nm and 50 nm Si-NPs resulted in different levels of QS,
although both Si-NPs were synthesized using the same method.
Based on the nanoparticle synthesis methods and TGA analy-
ses, we determined that the 15 nm Si-NPs carry 0.06µmol β-
CD/mg Si-NP complex, while the 50 nm Si-NPs carry 0.15µmol
β-CD/mg Si-NP complex, indicating that the surface densities
of the two Si-NPs are different. Additionally, the surface area
of the 50 nm Si-NPs is more than ten times the surface area
of the 15 nm Si-NPs, which may have provided for more space
between individual β-CD molecules and allowed for more effi-
cient binding with the HSLs. Given that a 50 nm Si-NP can
carry 1.7 times more β-CD than a 15 nm Si-NP, a higher dose
of 15 nm Si-NPs was used to treat the samples to achieve com-
parable levels of β-CD. Three major possibilities exist to explain
the difference in results. First, the higher concentration of Si-NPs
aggregated in solution, making more of the functional groups
unavailable on the smaller Si-NP. Alternatively, the β-CD may
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have been too dilute among the 15 nm Si-NPs and therefore
did not act differently than dissolved β-CD. Lastly, it is pos-
sible that the 15 nm Si-NPs behave differently than 50 nm Si-
NPs in an aqueous solution (Vertegel et al., 2004; Jiang et al.,
2008). It has been shown that the surface modifications of sil-
ica affect the dispersion of Si-NPs, and that smaller-sized Si-NPs
have unique physicochemical properties and optical absorption
characteristics (Rahman et al., 2009). Therefore, smaller nanopar-
ticles with a low surface density may behave differently than
larger nanoparticles with a higher surface density. In summary,
it is likely that the β-CD dose carried by the 15 nm Si-NPs
behaved differently than the 50 nm Si-NPs, and therefore was
unable to impact QS more significantly than free β-CD. The
larger 50 nm Si-NPs, in contrast, were able to carry a higher dose
of β-CD on fewer nanoparticles, and directly influenced QS in
V. fischeri.
Previous studies have reported the use of QS antagonists and
inhibitors to successfully interfere with bacterial QS (Dong et al.,
2007; Hong et al., 2012; Stacy et al., 2012; Welsh et al., 2015).
QS antagonists are often plant- and algal-based compounds that
bind to LuxR-type receptors and prevent the complex from
initating QS. Alternatively, QS inhibitors include both natural
and synthetic compounds that either degrade (i.e., enzymes) or
inhibit HSLs. Many propose that these anti-virulence strategies
will decrease selective pressure; however, the risk of antibiotic
resistance cannot be eliminated given the rapid rate of bacte-
rial revolution (Rasko and Sperandio, 2010). Our nanoparticle-
based QS inhibitors also reduce the risk of antibiotic resistance by
delivering high concentrations of the quenching compoundwith-
out excessive loss of the compound into the microbial environ-
ment. This method allows us to specficially target harmful bacte-
ria while reducing side effects often incurred by broad-spectrum
antibiotics. By delivering a highly concentrated compound to a
localized environment, the bacteria are treated quickly and have
less time to respond and adapt. Our study represents one of
the first attempts to deliver QS quenching compounds to bac-
teria via functionalized nanoparticles. Other studies have used
antimicrobial nanoparticles, such as silver and titanium diox-
ide, to kill bacteria or eliminate an infection. However, bacte-
ria have evolved multiple resistance mechanisms against these
nanoparticles (Rizzello and Pompa, 2014). Our study is signifi-
cant because it utilizes the size and capacity of nanoparticles and
the strength and relative safety of a QS quenching compound
to target and weaken bacteria. This technology could be poten-
tially redesigned to carry highly specific compounds in an effort
to further reduce selective pressure and eliminate harmful side
effects.
In this study, we have demonstrated that functionalized sil-
ica nanoparticles can be used to enhance the role of quenching
agents in vitro. Specifically, we demonstrated that β-CD is able
to bind HSLs and down-regulate bacterial QS genes. We have
found that the quenching ability of β-CD was much greater on
functionalized 50 nm Si-NPs, and provides a strong model for
future designs. Here, with the advent of nanotechnology, we have
demonstrated a unique ability (and tool) to specifically target bac-
terial communication, which may be used to penetrate biofilms
and eliminate infections.
Materials and Methods
Diffusion Study
NMR diffusion measurements were performed on a Varian Mer-
cury/VX 400 spectrometer operating at 400.273 MHz (1H).
Pulsed-field gradient spin echoes with varying gradient inten-
sity were collected with the Doneshot (Pelta et al., 2002) pulse
sequence that was included with VNMRJ 2.2D software. The
standard Varian Performa I pulsed field gradient amplifier and
5mmbroadband probe were capable of producing amaximum of
20 gauss/cm field gradients. Spectra were taken at ambient tem-
perature with bipolar gradient pulses of 4ms and a diffusion delay
of 100ms. All data processing was done with the Varian DOSY
software package.
Bacteria and Growth Media
V. fischeri JB10 is a derivative of the ES114 strain that contains
a chromosomal gfp reporter within the lux operon, resulting in
luxI-gfp-CDABEG (Bose et al., 2007). The strain was prepared by
and obtained from Professor Eric Stabb (Univ. Georgia, Athens,
GA). V. fischeri JB10 was cultured from a glycerol stock and
grown in marine broth (Difco 2216) to exponential phase. The
cells were then transferred to defined minimal medium (Studer
et al., 2008) for an optical density of approximately 0.1 (Abs600nm)
for the growth and RNA extraction experiments.
Bioluminescence Response during Exposure to
Nanoparticles
V. fischeri JB10 was grown in marine broth to exponential
phase and then transferred (0.5%) to a defined minimal medium
(Studer et al., 2008). For growth experiments, 96-well plates
were incubated at 28◦C in a Victor X Multilabel plate reader
for 24 h. Optical density was measured at 600 nm and GFP flu-
orescence was measured with a 485/20 nm excitation filter and a
528/20 nm emission filter. Bioluminescence was also measured.
All measurements were conducted every 2 h for 24 h follow-
ing 10 s of vigorous shaking. The total volume of each well
was 200µL, which included either 250 nM β-CD, 2mM β-CD,
15 nm SiO2 nanoparticles (2.75×10
−3 mg/mL NPs), 15 nm SiO2
nanoparticles functionalized with 155 nM β-CD (2.75 × 10−3
mg/mL NPs), 50 nm SiO2 nanoparticles (8.9 × 10
−4 mg/mL
NPs), or 50 nm SiO2 nanoparticles functionalized with 133 nM
β-CD (8.9 × 10−4 mg/mL NPs). Cultures also included 125 nM
3OC6-HSL, 0.25 nM C8-HSL, or both 125 nM 3OC6-HSL and
0.25 nM C8-HSL. All treatments were added at time zero. A
growth experiment was also performed with 600 nm SiO2 parti-
cles (data not shown, no cell growth occurred), α-cyclodextrin,
2-hydroxypropyl-β-CD, and methyl-β-CD. Cyclodextrins were
obtained from Sigma Aldrich.
Quantitative PCR and Transcript Analysis: lux
Transcription during Exposure to Nanoparticles
V. fischeri JB10 was grown in marine broth to exponential phase
and then transferred (1%) to a defined minimal medium (Studer
et al., 2008). Cultures were grown at 28◦C and 200 rpm in 250mL
shake flasks with a working volume of 50mL for 8 h. Treatments
were added at 8 h and exposure/growth continued for 4 h. At 12 h
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of total growth, 2mL of cells were harvested by centrifugation
at 2000 × g (5min). Cells were treated with 2 mg/mL lysozyme
in TE buffer for 10minutes and then homogenized with a nee-
dle and syringe. RNA was extracted with PureLink RNA Mini
Kit (Ambion) and on-column DNA digestion was performed
with PureLink PCRMicro Kit (Invitrogen). qPCR was performed
on a BioRad CFX96 Real Time System with a C1000 Thermal
Cycler. Data was analyzed by the Livak method (11 Ct) and fold
changes were determined by using 2−11Ct .
Primers were designed for luxR and luxA with NCBI’s
Primer-BLAST. Primer sequences for luxA were ATCCC-
CATCTTCGTGAACGG and ACAGAACATGGCCACGACAT.
Primer sequences for luxR were CGTGGGCGAGTGAAG
GAAAA and TGGCGCCAGTTAAAATTGCT. Primer
sequences for the 16S rRNA gene were GTTTGATCATGGCTCA
GATTG and CTACCTTGTTACGACTTCACC (Hoffmann
et al., 2010). The 16S rRNA gene was used as the reference gene.
All primers were ordered from Integrated DNA Technologies
(Coralville, Iowa). Genomic DNA from V. fischeri JB10 was
amplified with the primers and sequenced by Selah Genomics
(Columbia, SC) to check the accuracy of the primers.
Reagents for Nanoparticle Synthesis
All chemicals were obtained from Fisher or Acros and used
as received unless otherwise specified. 3-aminopropyldimethyl-
ethoxysilane was obtained from Gelest, Inc. (Morrisville, PA).
Nanoparticle Characterization
The nanoparticles were characterized according to methods
establish by Wang and Benicewicz (2013) and Wang et al.
(2014). Infrared spectra were determined with a BioRad Excal-
ibur FTS3000 spectrometer. UV-vis spectra were measured
with a Perkin-Elmer Lambda 4C UV-vis spectrophotometer.
Infrared spectra were recorded with a Perkin-Elmer Spec-
trum 100 spectrometer. TGA was conducted using a SDT
Q600 TGA system (TA Instruments) with a temperature
ramping from 25 to 900◦C at a rate of 10◦C/min under
nitrogen.
Preparation of Monolayer Dye-Labeled β-CD
Functionalized Silica Nanoparticles
A method has recently been developed for controlling the
density of surface carboxylic acid functional groups coated
onto the synthesized silicon dioxide Si-NPs (Cash et al., 2012;
Wang and Benicewicz, 2013). Using this method, we coated
a monolayer of β-CD onto the fluorescent Si-NPs via a cou-
pling reaction between the β-CD hydroxyl groups and the
carboxylic acids on the monolayer of dye-labeled Si-NPs.
The carboxylic acid coated Si-NPs were prepared based on a
ring-opening reaction between succinic anhydride and amino-
functionalized silica Si-NPs with surface graft densities rang-
ing from 0.10 to 0.65 groups/nm2. Thus, the graft density
of β-CD functionalized Si-NPs were tailored by varying the
feed ratio between bare Si-NPs and amino-silane compound.
Specifically, a dimethylformamide (DMF) solution of β-CD
(70.56 mg, 62.16µmol), N,N’-Dicyclohexylcarbodiimide (DCC,
10.3mg, 49.73µmol) and 4-Dimethylaminopyridine (DMAP,
0.5063mg, 4.144µmol) were added to a 15mL DMF solu-
tion of dye-labeled carboxylic acid-functionalized silica nanopar-
ticles (graft density: 0.24 groups/nm2, 0.7281 g). The reac-
tion was stirred at room temperature overnight. The reac-
tion solution was then poured into 200mL ethyl ether fol-
lowed by centrifugation at 3000 rpm for 5min. The recovered
particles were then redispersed in 20mL of ethanol and sub-
jected to dialysis process to further remove impurities. The dye-
labeled β-CD coated silica nanoparticles were finally dissolved
in ethanol/water mixture solvents for further use. The prepa-
ration of dye-labeled monolayer carboxylic acid functionalized
silica nanoparticles was based on our previous work (Cash et al.,
2012).
Statistical Analysis
Statistical significance for all experiments was determined by a
repeated measures analysis of variance test followed by an aposte-
riori pairwise muliple comparision procedure (SigmaPlot, Systat
Software, San Jose, CA).
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